|
|
||||||||||||||||||||
Roche Diagnostics
Our passion to improve lives is the driving force behind Roche Diagnostics innovation in the diagnostics industry. We develop and produce medical tests that provide information to assist medical decision makers in delivering the best patient care. Our products not only diagnose disease, they also monitor drug therapies to provide physicians with accurate information to ensure their patients are receiving the most effective treatment.
As a global leader in diagnostics, we constantly work to improve our products and services. Our expertise in a variety of diagnostic technologies allows us to introduce innovative products that shape new markets and take diagnostics into new dimensions. This expertise and a global presence help Roche Diagnostics respond quickly to a variety of global health issues. We also have a broad portfolio of diagnostics tools for congestive heart failure, HIV, hepatitis B and C, fertility testing, diabetes and many other diseases. This wide array of innovative testing products and services is supplied to researchers, physicians, patients, hospitals and laboratories worldwide.
Roche Diagnostics focuses on actionable health information. Actionable health information takes information from multiple diagnostic sources and translates it into data that helps our customers (laboratories, researchers, physicians and patients) to make informed decisions about prevention or therapy. Providing the right tools and the right information is the future in healthcare, and Roche Diagnostics is on the cutting edge, integrating information for a comprehensive, actionable healthcare solution.
Centralized Diagnostics provides integrated, high-performance analytical systems to optimize laboratory management from pre-analytical to post-analytical processes. We develop high quality solutions for diagnostics laboratoriesfrom analyzers and test reagents to work-flow solutions. To maintain its leadership in technology and quality, Roche minimizes third party products with more than 75 percent of its assay portfolio developed and manufactured in-house.
Molecular Diagnostics focuses on developing predictive tools that can assist in patient prognosis and treatment. Our portfolio is based on polymerase chain reaction (PCR) technologythe worlds leading nucleic acid amplification testing (NAT) technologyand applies clinical diagnostics in six key areas: virology, womens health, microbiology, blood screening, genomics and oncology. PCR has provided the basis for unprecedented advances in the diagnosis and monitoring of life-threatening diseases, such as HIV and hepatitis and as an aid in genetic identification. We also produce highly sensitive blood screening applications that assist in safeguarding the nations blood, organ and tissue supply.
Our passion to improve lives is the driving force behind Roche Diagnostics innovation in the diagnostics industry. We develop and produce medical tests that provide information to assist medical decision makers in delivering the best patient care. Our products not only diagnose disease, they also monitor drug therapies to provide physicians with accurate information to ensure their patients are receiving the most effective treatment.
As a global leader in diagnostics, we constantly work to improve our products and services. Our expertise in a variety of diagnostic technologies allows us to introduce innovative products that shape new markets and take diagnostics into new dimensions. This expertise and a global presence help Roche Diagnostics respond quickly to a variety of global health issues. We also have a broad portfolio of diagnostics tools for congestive heart failure, HIV, hepatitis B and C, fertility testing, diabetes and many other diseases. This wide array of innovative testing products and services is supplied to researchers, physicians, patients, hospitals and laboratories worldwide.
Roche Diagnostics focuses on actionable health information. Actionable health information takes information from multiple diagnostic sources and translates it into data that helps our customers (laboratories, researchers, physicians and patients) to make informed decisions about prevention or therapy. Providing the right tools and the right information is the future in healthcare, and Roche Diagnostics is on the cutting edge, integrating information for a comprehensive, actionable healthcare solution.
Centralized Diagnostics provides integrated, high-performance analytical systems to optimize laboratory management from pre-analytical to post-analytical processes. We develop high quality solutions for diagnostics laboratoriesfrom analyzers and test reagents to work-flow solutions. To maintain its leadership in technology and quality, Roche minimizes third party products with more than 75 percent of its assay portfolio developed and manufactured in-house.
Molecular Diagnostics focuses on developing predictive tools that can assist in patient prognosis and treatment. Our portfolio is based on polymerase chain reaction (PCR) technologythe worlds leading nucleic acid amplification testing (NAT) technologyand applies clinical diagnostics in six key areas: virology, womens health, microbiology, blood screening, genomics and oncology. PCR has provided the basis for unprecedented advances in the diagnosis and monitoring of life-threatening diseases, such as HIV and hepatitis and as an aid in genetic identification. We also produce highly sensitive blood screening applications that assist in safeguarding the nations blood, organ and tissue supply.
